270 related articles for article (PubMed ID: 28441965)
1. Evaluation of a DNA Aβ42 vaccine in adult rhesus monkeys (Macaca mulatta): antibody kinetics and immune profile after intradermal immunization with full-length DNA Aβ42 trimer.
Lambracht-Washington D; Fu M; Frost P; Rosenberg RN
Alzheimers Res Ther; 2017 Apr; 9(1):30. PubMed ID: 28441965
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a DNA Aβ42 Vaccine in Aged NZW Rabbits: Antibody Kinetics and Immune Profile after Intradermal Immunization with Full-Length DNA Aβ42 Trimer.
Lambracht-Washington D; Fu M; Wight-Carter M; Riegel M; Rosenberg RN
J Alzheimers Dis; 2017; 57(1):97-112. PubMed ID: 28222511
[TBL] [Abstract][Full Text] [Related]
3. Active full-length DNA Aβ
Rosenberg RN; Fu M; Lambracht-Washington D
Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
[TBL] [Abstract][Full Text] [Related]
4. DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model.
Lambracht-Washington D; Qu BX; Fu M; Eagar TN; Stüve O; Rosenberg RN
JAMA; 2009 Oct; 302(16):1796-802. PubMed ID: 19861672
[TBL] [Abstract][Full Text] [Related]
5. DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation.
Lambracht-Washington D; Qu BX; Fu M; Anderson LD; Stüve O; Eagar TN; Rosenberg RN
Cell Mol Neurobiol; 2011 Aug; 31(6):867-74. PubMed ID: 21625960
[TBL] [Abstract][Full Text] [Related]
6. Intradermal active full-length DNA Aβ42 immunization via electroporation leads to high anti-Aβ antibody levels in wild-type mice.
Rosenberg RN; Fu M; Lambracht-Washington D
J Neuroimmunol; 2018 Sep; 322():15-25. PubMed ID: 29958693
[TBL] [Abstract][Full Text] [Related]
7. Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease.
Qu B; Rosenberg RN; Li L; Boyer PJ; Johnston SA
Arch Neurol; 2004 Dec; 61(12):1859-64. PubMed ID: 15596606
[TBL] [Abstract][Full Text] [Related]
8. A noninflammatory immune response in aged DNA Aβ42-immunized mice supports its safety for possible use as immunotherapy in AD patients.
Lambracht-Washington D; Rosenberg RN
Neurobiol Aging; 2015 Mar; 36(3):1274-81. PubMed ID: 25725942
[TBL] [Abstract][Full Text] [Related]
9. Changes in the brain transcriptome after DNA Aβ42 trimer immunization in a 3xTg-AD mouse model.
Lambracht-Washington D; Fu M; Hynan LS; Rosenberg RN
Neurobiol Dis; 2021 Jan; 148():105221. PubMed ID: 33316368
[TBL] [Abstract][Full Text] [Related]
10. Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice.
Qu BX; Xiang Q; Li L; Johnston SA; Hynan LS; Rosenberg RN
J Neurol Sci; 2007 Sep; 260(1-2):204-13. PubMed ID: 17574274
[TBL] [Abstract][Full Text] [Related]
11. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
Kim HD; Jin JJ; Maxwell JA; Fukuchi K
Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
[TBL] [Abstract][Full Text] [Related]
12. A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease.
Lambracht-Washington D; Qu BX; Fu M; Anderson LD; Eagar TN; Stüve O; Rosenberg RN
J Neuroimmunol; 2013 Jan; 254(1-2):63-8. PubMed ID: 23036592
[TBL] [Abstract][Full Text] [Related]
13. Preventive immunization of aged and juvenile non-human primates to β-amyloid.
Kofler J; Lopresti B; Janssen C; Trichel AM; Masliah E; Finn OJ; Salter RD; Murdoch GH; Mathis CA; Wiley CA
J Neuroinflammation; 2012 May; 9():84. PubMed ID: 22554253
[TBL] [Abstract][Full Text] [Related]
14. Developing novel immunogens for a safe and effective Alzheimer's disease vaccine.
Lemere CA
Prog Brain Res; 2009; 175():83-93. PubMed ID: 19660650
[TBL] [Abstract][Full Text] [Related]
15. Abeta42 gene vaccination reduces brain amyloid plaque burden in transgenic mice.
Qu B; Boyer PJ; Johnston SA; Hynan LS; Rosenberg RN
J Neurol Sci; 2006 May; 244(1-2):151-8. PubMed ID: 16556449
[TBL] [Abstract][Full Text] [Related]
16. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.
Kim HD; Tahara K; Maxwell JA; Lalonde R; Fukuiwa T; Fujihashi K; Van Kampen KR; Kong FK; Tang DC; Fukuchi K
J Gene Med; 2007 Feb; 9(2):88-98. PubMed ID: 17219449
[TBL] [Abstract][Full Text] [Related]
17. [Specific humoral immune response in Rhesus monkeys vaccinated immune response with Abeta42 peptide vaccine].
Li SB; Wang HQ; Lin X; Xu J; Yao ZB
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):202-4. PubMed ID: 15766406
[TBL] [Abstract][Full Text] [Related]
18. Delivery of a DNA vaccine for Alzheimer's disease by electroporation versus gene gun generates potent and similar immune responses.
Davtyan H; Ghochikyan A; Movsesyan N; Ellefsen B; Petrushina I; Cribbs DH; Hannaman D; Evans CF; Agadjanyan MG
Neurodegener Dis; 2012; 10(1-4):261-4. PubMed ID: 22301697
[TBL] [Abstract][Full Text] [Related]
19. Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice.
Petrushina I; Ghochikyan A; Mkrtichyan M; Mamikonyan G; Movsesyan N; Ajdari R; Vasilevko V; Karapetyan A; Lees A; Agadjanyan MG; Cribbs DH
J Neuroinflammation; 2008 Sep; 5():42. PubMed ID: 18823564
[TBL] [Abstract][Full Text] [Related]
20. Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.
Matsuo K; Okamoto H; Kawai Y; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
J Neuroimmunol; 2014 Jan; 266(1-2):1-11. PubMed ID: 24315156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
